ArticleHepatology international2023

Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study.

Yu Jun Wong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.